梅波利祖马布可降低鼻息肉组织中的炎症性乙氨基基基,并恢复组织学变化
A Matucci1, M Accinno2, G Maggiore3
1Immunoallergology Unit, Careggi University Hospital, Florence, Italy.
概括
鼻息肉中的炎症性乙氨基酸 (iEos) 与慢性鼻炎的严重程度相关. 梅波利祖马布治疗显著降低了IEOS,改善了患者的治疗结果和鼻腔控制.
科学领域:
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 肺部病理学 肺部病理学
背景情况:
- 乙酸性炎症是2型慢性鼻炎与鼻多重症 (CRSwNP) 的核心.
- 已经确定了通过CD62L表达来定义的两个乙氨基基基亚群,即静态的 (rEos) 和炎症的 (iEos).
- 介质蛋白-5 (IL-5) 是CRSwNP疗法的关键标.
研究的目的:
- 为了研究乙氨基基子群和CRSwNP严重程度之间的关联.
- 为了评估梅波利祖马布对CRSwNP患者组织乙氨基基基亚群的影响.
主要方法:
- 流式细胞计量用于分析15名CRSwNP患者的鼻多组织中的乙氨基基基亚群 (iEos和rEos).
- 组织样本在基线和梅波利祖马布治疗后被分析.
- 评估了iEos比例,CRSwNP严重程度和治疗反应之间的相关性.
主要成果:
- 组织iEos的比例与更高的CRSwNP严重程度和更差的生活质量得分相关 (SNOT-22,L-K).
- 梅波利祖马布显著减少了组织iEos,更大的减少与改善的生活质量和严重性得分有关.
- 梅波利祖马布治疗导致组织学改善,包括减少胀和杯状细胞增生.
结论:
- 组织iEos水平表明CRSwNP中的鼻控制不佳.
- 梅波利祖马布有效地减少组织iEos,与增强的治疗效果相关.
- 梅波利祖马布减少iEos与CRSwNP的显著临床和组织学改善有关.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
471
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
471
01:19Antiasthma Drugs: Leukotriene Modifiers
489
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
489
01:17Drugs Used in Lower Respiratory Disorders: Overview
610
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
610
01:26Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
01:20Asthma: Pathogenesis and Management
607
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
607
01:24Antiasthma Drugs: Methylxanthines
413
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
413